Waters Kevin 4
4 · PROCEPT BioRobotics Corp · Filed Jun 10, 2026
Research Summary
AI-generated summary of this filing
PROCEPT (PRCT) CFO Kevin Waters Sells 357 Shares
What Happened
- Kevin Waters, EVP and CFO of PROCEPT BioRobotics (PRCT), sold 357 shares on June 8, 2026 at $28.48 per share, producing reported proceeds of $10,167. The filing shows this was a sale (disposition) tied to tax withholding.
Key Details
- Transaction date and price: June 8, 2026 — 357 shares at $28.48 each.
- Proceeds reported: $10,167 (rounded).
- Shares owned after transaction: Not reported in the provided filing.
- Footnote: The shares were sold pursuant to the issuer’s sell-to-cover process to satisfy tax withholding obligations related to Restricted Stock Units that vested on June 5, 2026 (footnote F1).
- Filing date/timeliness: Form 4 filed June 10, 2026 (within the typical two-business-day reporting window); not flagged as late.
Context
- This was a routine sell-to-cover to satisfy tax withholding from RSU vesting, which is common and does not by itself indicate a change in the insider’s view of the company. Sales for tax withholding generally carry less informational weight than discretionary open-market sales.
Insider Transaction Report
Form 4
Waters Kevin
EVP, CFO
Transactions
- Sale
Common Stock
[F1]2026-06-08$28.48/sh−357$10,167→ 151,201 total
Footnotes (1)
- [F1]The shares were sold by the reporting person pursuant to the Issuer's sell-to-cover process for tax withholding obligations in connection with the vesting of the Restricted Stock Units on June 5, 2026.
Signature
/s/ Jonathan Stone, Attorney-in-Fact for Kevin Waters|2026-06-10